Patents by Inventor Ling Liang

Ling Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190321389
    Abstract: Methods and compositions for treating diabetic retinopathy employ an ophthalmic, topical formulation of micro-RNA 195 packaged in or on a nanoparticle or vesicle.
    Type: Application
    Filed: December 12, 2017
    Publication date: October 24, 2019
    Inventors: Suh-Hang Hank JUO, Chung-Ling LIANG, Tzu-Ming WANG
  • Publication number: 20190300961
    Abstract: A kit for determining ctDNA concentration and a method for determining ctDNA concentration is disclosed, wherein the method comprising dissolving extracted ctDNA in Tris-HCl buffer with pH>7.0 and adding into the buffer 2,7-bis(1-methyl-4-vinylpyridine)-9-ethylcarbazole iodised salt as a molecular probe, calculating the concentration of ctDNA in the solution by measuring the Fluorescence intensity of the solution. It has extremely high sensitivity in the determination of 0 ?g/ml˜50 ?g/ml ctDNA solution.
    Type: Application
    Filed: April 3, 2018
    Publication date: October 3, 2019
    Inventors: WENFENG YU, SHI ZHOU, ZHI HUANG, BI WANG, RUI GAO, DAI WEI ZHAO, HAI ZHUANG, YA LING LIANG
  • Publication number: 20190228841
    Abstract: Disclosed herein is Arrowland, a web-based software tool for inputting, managing and viewing multiomics data, such as transcriptomics, proteomics, metabolomics and fluxomics data in an interactive, intuitive and multiscale system.
    Type: Application
    Filed: January 22, 2019
    Publication date: July 25, 2019
    Inventors: Hector Garcia Martin, Garrett W. Birkel, Ling Liang, William Morrell, Mark Forrer
  • Patent number: 10179913
    Abstract: The present invention is directed to anti-sense microRNA-328 in a form of oligodeoxyribonucleotides, or locked nucleic acid (LNA)-modified, and phosphorothioated (PS) bond-modified oligonucleotides. The present invention is also directed to a pharmaceutical composition comprising the anti-sense microRNA-328 composition and a pharmaceutically acceptable carrier. The present invention is further directed to a method for preventing or treating myopia by administering to a subject the anti-sense microRNA-328 composition. A preferred route of administration is topical administration to the eyes.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: January 15, 2019
    Assignee: Kaohsiung Medical University
    Inventors: Suh-Hang H. Juo, Edward Hsi, Chung-Ling Liang
  • Patent number: 10061166
    Abstract: A liquid crystal display panel includes a first and a second substrate, scan lines, data lines, pixel structures, a counter electrode layer, and a liquid crystal layer. The scan lines, the data lines, and the pixel structures are located above the first substrate. Each of the pixel structures includes a first active device and a first pixel electrode. The first active device is electrically connected to the scan line and the data line. The first pixel electrode is electrically connected to the first active device and has a plurality of first stripe portions. Two adjacent first stripe portions define a first slit. The first stripe portion has a width L, the first slit has a width S, the first stripe portions have a pitch p there between, and p=L+S. The liquid crystal layer is disposed between the first and second substrates and has a thickness d.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: August 28, 2018
    Assignee: AU OPTRONICS CORPORATION
    Inventors: Jieh-Wen Tsung, Cho-Yan Chen, Wan-Ling Liang, Cheng-Wei Lai, Tien-Lun Ting
  • Publication number: 20180216109
    Abstract: The present invention is directed to anti-sense microRNA-328 in a form of oligodeoxyribonucleotides, or locked nucleic acid (LNA)-modified, and phosphorothioated (PS) bond-modified oligonucleotides. The present invention is also directed to a pharmaceutical composition comprising the anti-sense microRNA-328 composition and a pharmaceutically acceptable carrier. The present invention is further directed to a method for preventing or treating myopia by administering to a subject the anti-sense microRNA-328 composition. A preferred route of administration is topical administration to the eyes.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 2, 2018
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Suh-Hang H. Juo, Edward Hsi, Chung-Ling Liang
  • Publication number: 20170294795
    Abstract: The wireless charging device contains a mobile power member. The mobile power member contains a processor, a battery module, a temperature detection module, a magnetic detection module, an adjustable power conversion module, a wireless charging module, and a digital potentiometer. The processor is electrically connected to the battery module, the temperature detection module, the digital potentiometer, and the magnetic detection module. The digital potentiometer is electrically connected to the adjustable power conversion module. The adjustable power conversion module is electrically connected to the battery module and the wireless charging module.
    Type: Application
    Filed: April 11, 2016
    Publication date: October 12, 2017
    Inventor: Yun-Ling Liang
  • Patent number: 9738783
    Abstract: Curable compositions comprising an epoxy mixture comprising a) an epoxy mixture comprising i) a first epoxy component comprising epoxy phenol novolac oligomers having a content of 2-functional monomers of less than 10 weight percent based on the total weight of the first epoxy component and having an epoxide equivalent weight in the range of 170 to 200; and ii) a second epoxy component comprising an epoxy resin having monomers with an average functionality of at least 2 and b) a hardener, are disclosed. The curable compositions can be used to prepare prepregs for hot-melt applications.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: August 22, 2017
    Assignee: BLUE CUBE IP LLC
    Inventors: Yi Ling Liang, William W. Fan, Stanley E. Moore, Rui Xie, Mark B. Wilson
  • Patent number: 9670489
    Abstract: The present disclosure provides a method for treating and/or preventing myopia, including: administering an RNA interference (RNAi) to a subject, wherein the RNA interference is capable of counteracting another RNA interference, and the other RNA interference is an RNA interference capable of inhibiting an expression of PAX-6 gene, and the RNA interference capable of inhibiting an expression of PAX-6 gene comprises microRNA-328.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: June 6, 2017
    Assignee: Kaohsiung Medical University
    Inventors: Suh-Hang Juo, Ku-Chung Chen, Edward Hsi, Chung-Ling Liang
  • Publication number: 20170153514
    Abstract: A liquid crystal display panel includes a first and a second substrate, scan lines, data lines, pixel structures, a counter electrode layer, and a liquid crystal layer. The scan lines, the data lines, and the pixel structures are located above the first substrate. Each of the pixel structures includes a first active device and a first pixel electrode. The first active device is electrically connected to the scan line and the data line. The first pixel electrode is electrically connected to the first active device and has a plurality of first stripe portions. Two adjacent first stripe portions define a first slit. The first stripe portion has a width L, the first slit has a width S, the first stripe portions have a pitch p there between, and p=L+S. The liquid crystal layer is disposed between the first and second substrates and has a thickness d.
    Type: Application
    Filed: November 30, 2016
    Publication date: June 1, 2017
    Inventors: Jieh-Wen TSUNG, Cho-Yan CHEN, Wan-Ling LIANG, Cheng-Wei LAI, Tien-Lun TING
  • Publication number: 20160208091
    Abstract: Curable compositions comprising an epoxy mixture comprising a) an epoxy mixture comprising i) a first epoxy component comprising epoxy phenol novolac oligomers having a content of 2-functional monomers of less than 10 weight percent based on the total weight of the first epoxy component and having an epoxide equivalent weight in the range of 170 to 200; and ii) a second epoxy component comprising an epoxy resin having monomers with an average functionality of at least 2 and b) a hardener, are disclosed. The curable compositions can be used to prepare prepregs for hot-melt applications.
    Type: Application
    Filed: September 16, 2014
    Publication date: July 21, 2016
    Inventors: Yi Ling LIANG, William W. FAN, Stanley E. MOORE, Rui XIE, Mark B. WILSON
  • Patent number: 9268337
    Abstract: A method of measuring contamination in fluid that is expelled from a food processing system is presented. The method of measuring is carried out with fluorescence. The fluid is typically allowed to enter into an energy transfer system, but if the contamination exceeds a certain level, the fluid should be prevented from entering the energy transfer system. The fluid is generally comprised of water expelled from a sugar processing operation.
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: February 23, 2016
    Assignee: Ecolab USA Inc.
    Inventors: Ling Liang, Patrick P. Chen, Rodney H. Banks, Michael W. Willer, Narasimha M. Rao
  • Publication number: 20160010087
    Abstract: The present disclosure provides a method for treating and/or preventing myopia, including: administering an RNA interference (RNAi) to a subject, wherein the RNA interference is capable of counteracting another RNA interference, and the other RNA interference is an RNA interference capable of inhibiting an expression of PAX-6 gene, and the RNA interference capable of inhibiting an expression of PAX-6 gene comprises microRNA-328.
    Type: Application
    Filed: March 31, 2015
    Publication date: January 14, 2016
    Inventors: Suh-Hang JUO, Ku-Chung CHEN, Edward HSI, Chung-Ling LIANG
  • Publication number: 20150198540
    Abstract: The invention provides devices, methods, and compositions for dry chemical reagents to measure calcium, magnesium (total hardness), and other analytes in water using colorimetric devices. The measurement may be a one-step procedure without the need of dilution and multi-step preparation, so that it can be easily employed by untrained personnel. The chemical reagents may include dyes, buffer reagents, masking reagents, competing ligands, and other chemicals such as fillers. The chemical reagents may be grinded together as a homogenous fine powder, equally dispensed into small containers for each test or dried as film or solid using the means of air, low heat or vacuum. The composition may be easily dissolved into water samples and stable for long term storage.
    Type: Application
    Filed: January 10, 2014
    Publication date: July 16, 2015
    Applicant: Ecolab USA Inc.
    Inventors: Hua Zheng, Ning Jin, Fei Xia, Ling Liang, Chunbo Yu, Lin Jiang, Ling Feng Han
  • Publication number: 20140060659
    Abstract: A method of measuring contamination in fluid that is expelled from a food processing system is presented. The method of measuring is carried out with fluorescence. The fluid is typically allowed to enter into an energy transfer system, but if the contamination exceeds a certain level, the fluid should be prevented from entering the energy transfer system. The fluid is generally comprised of water expelled from a sugar processing operation.
    Type: Application
    Filed: October 3, 2011
    Publication date: March 6, 2014
    Inventors: Ling Liang, Patrcik Pu Chen, Rodney H. Banks, Michael W. Willer, Narasimha M. Rao, Christopher Brant Wilson
  • Publication number: 20120256275
    Abstract: A manufacturing method of a metal gate structure includes first providing a substrate having a dummy gate formed thereon. The dummy gate includes a high-K gate dielectric layer, a bottom barrier layer, a first etch stop layer and a sacrificial layer sequentially and upwardly stacked on the substrate. Then, the sacrificial layer is removed to form a gate trench with the first etch stop layer exposed on the bottom of the gate trench. After forming the gate trench, a first work function metal layer is formed in the gate trench.
    Type: Application
    Filed: April 6, 2011
    Publication date: October 11, 2012
    Inventors: Hsin-Fu Huang, Chi-Mao Hsu, Kun-Hsien Lin, Chin-Fu Lin, Tzung-Ying Lee, Min-Chuan Tsai, Yi-Wei Chen, Bin-Siang Tsai, Ted Ming-Lang Guo, Ger-Pin Lin, Yu-Ling Liang, Yen-Ming Chen, Tsai-Yu Wen
  • Publication number: 20120245108
    Abstract: The present invention relates to a method of modulating complement factor B (CFB) expression in cells, comprising administering an effective amount of tannic acid to the cells. This method can be applied in treating or prophylaxis of the disease, disorder or medical condition associated to complement factor B (CFB) expression.
    Type: Application
    Filed: March 23, 2011
    Publication date: September 27, 2012
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Suh-Hang Hank Juo, Wen-Wen Chou, Jing-Mei Wu, Chung-Ling Liang
  • Publication number: 20110129838
    Abstract: A method and kit for determining an increased risk of developing myopia in a subject is provided by detecting an SNP in the BICD1 gene. The SNP is selected from a group consisting of rs10844126 (A/C), rs1151029 (A/T), rs2650122 (C/T), rs10771923 (A/G), rs1151009 (T/C), rs2125173 (A/G) and rs161959 (C/G). When the presence of the risk allele associated with myopia is detected at the SNP, the subject is determined in an increased risk of developing myopia.
    Type: Application
    Filed: February 8, 2011
    Publication date: June 2, 2011
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Suh-Hang Hank Juo, Chung-Ling Liang, Edward Hsi
  • Publication number: 20110014960
    Abstract: The present invention discloses a game blog platform (GBP) system, including a processing unit, to control and manage the system; a platform generating module, to generate a platform for a plurality of users; an education and training module, to provide the function of education and training for the plurality of users; a planning module, to provide function of planning for the plurality of users; a matching module, to provide function of matching for the plurality of users; a game generating module, to provide the function of game generating for the plurality of users; an trading module, to provide the function of trading for the plurality of users; and a database/storage module, to provide the function of database and storage.
    Type: Application
    Filed: January 5, 2010
    Publication date: January 20, 2011
    Inventor: Tzu-Ling LIANG
  • Publication number: 20100125524
    Abstract: The present invention discloses a web transaction system and the method for the same. The web transaction system includes a plurality of merchant severs which deal with customers through a trading platform. Financial providers supply the merchant servers or customers with financial services respectively. A trustee service provider, coupled to the financial providers, provides the merchant servers with entrusting services for reduction in trading risks.
    Type: Application
    Filed: March 3, 2009
    Publication date: May 20, 2010
    Inventor: Tzu-Ling LIANG